These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30342499)

  • 21. Antimicrobial Resistance Surveillance Methods in Bangladesh: Present and Way Forward.
    Sujan MJ; Habib ZH; Rahman A; Rizvi SMS; Barua HT; Aboushady AT; Hasnat MA; Rasul SBG; Joh HS; Prifti K; Chi KK; Kwon SY; Clark A; Gautam S; Holm M; Marks F; Stelling J; Shaw A; Poudyal N
    Clin Infect Dis; 2023 Dec; 77(Suppl 7):S549-S559. PubMed ID: 38118018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Prevalence of Antimicrobial Resistance in Okayama from a National Database between 2018 and 2021.
    Fukushima S; Hagiya H; Uda K; Gotoh K; Otsuka F
    Acta Med Okayama; 2023 Jun; 77(3):255-262. PubMed ID: 37357626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying patient- and hospital-level antimicrobial resistance dynamics in
    Leclerc Q; Clements A; Dunn H; Hatcher J; Lindsay JA; Grandjean L; Knight GM
    J Med Microbiol; 2023 Jul; 72(7):. PubMed ID: 37431889
    [No Abstract]   [Full Text] [Related]  

  • 24. Establishment of a Sentinel Laboratory-Based Antimicrobial Resistance Surveillance Network in Ethiopia.
    Hazim C; Abubeker Ibrahim R; Westercamp M; Belete GA; Amare Kibret B; Kanter T; Yimer G; Adem TS; Stevenson KB; Urrego M; Kale KN; Omondi MW; VanderEnde D; Park BJ; Parsons MMB; Gallagher KM
    Health Secur; 2018; 16(S1):S30-S36. PubMed ID: 30480505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of antimicrobial resistance in the United Arab Emirates: the early implementation phase.
    Thomsen J; Abdulrazzaq NM; AlRand H;
    Front Public Health; 2023; 11():1247627. PubMed ID: 38074700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2018-2022.
    Canadian Nosocomial Infection Surveillance Program1
    Can Commun Dis Rep; 2024 Jun; 50(6):179-196. PubMed ID: 39132584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The barriers and facilitators of implementing a national laboratory-based AMR surveillance system in Cambodia: key informants' perspectives and assessments of microbiology laboratories.
    Mao S; Soputhy C; Lay S; Jacobs J; Ku GM; Chau D; Chhea C; Ir P
    Front Public Health; 2023; 11():1332423. PubMed ID: 38179556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006-2018.
    Saeed DK; Farooqi J; Shakoor S; Hasan R
    BMC Infect Dis; 2021 Dec; 21(1):1231. PubMed ID: 34876041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the COVID-19 pandemic on the surveillance of antimicrobial resistance.
    Hirabayashi A; Kajihara T; Yahara K; Shibayama K; Sugai M
    J Hosp Infect; 2021 Nov; 117():147-156. PubMed ID: 34562548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans.
    Schrijver R; Stijntjes M; Rodríguez-Baño J; Tacconelli E; Babu Rajendran N; Voss A
    Clin Microbiol Infect; 2018 Jun; 24(6):577-590. PubMed ID: 28970159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten-year resistance trends in pathogens causing healthcare-associated infections; reflection of infection control interventions at a multi-hospital healthcare system in Saudi Arabia, 2007-2016.
    Balkhy HH; El-Saed A; Alshamrani MM; Alsaedi A; Al Nasser W; El Gammal A; Aljohany SM; Almunif S; Arabi Y; Alqahtani S; Bonnie HB; Alghoribi M; Alothman A; Almohrij SA
    Antimicrob Resist Infect Control; 2020 Jan; 9(1):21. PubMed ID: 32000850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019-2020: General view of the pathogens' antibacterial susceptibility.
    Tokimatsu I; Matsumoto T; Tsukada H; Fujikura Y; Miki M; Morinaga Y; Sato J; Wakamura T; Kiyota H; Tateda K; Yanagisawa H; Sasaki T; Ikeda H; Horikawa H; Takahashi H; Seki M; Mori Y; Takeda H; Kurai D; Hasegawa N; Uwamino Y; Kudo M; Yamamoto M; Nagano Y; Nomura S; Tetsuka T; Hosokai M; Aoki N; Yamamoto Y; Iinuma Y; Mikamo H; Suematsu H; Maruyama T; Kawabata A; Sugaki Y; Nakamura A; Fujikawa Y; Fukumori T; Ukimura A; Kakeya H; Niki M; Yoshida K; Kobashi Y; Tokuyasu H; Yatera K; Ikegami H; Fujita M; Matsumoto T; Yanagihara K; Matsuda J; Hiramatsu K; Shinzato T
    J Infect Chemother; 2023 Aug; 29(8):731-743. PubMed ID: 37116613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of antimicrobial resistance laboratory-based surveillance capacity of hospitals in Zambia: findings and implications for system strengthening.
    Yamba K; Chizimu JY; Mudenda S; Lukwesa C; Chanda R; Nakazwe R; Simunyola B; Shawa M; Kalungia AC; Chanda D; Mateele T; Thapa J; Kapolowe K; Mazaba ML; Mpundu M; Masaninga F; Azam K; Nakajima C; Suzuki Y; Bakyaita NN; Wesangula E; Matu M; Chilengi R
    J Hosp Infect; 2024 Jun; 148():129-137. PubMed ID: 38621513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of the independent microbiology laboratory in supporting infection control programs in small to mid-sized hospitals].
    Yanagisawa H
    Rinsho Byori; 2009 May; 57(5):463-6. PubMed ID: 19522253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly sensitive detection of antimicrobial resistance genes in hospital wastewater using the multiplex hybrid capture target enrichment.
    Baba H; Kuroda M; Sekizuka T; Kanamori H
    mSphere; 2023 Aug; 8(4):e0010023. PubMed ID: 37222510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vancomycin MIC creep progresses in methicillin-resistant Staphylococcus aureus despite the national antimicrobial stewardship campaign: Single facility data in Japan.
    Fujimori T; Hagiya H; Iio K; Higashionna T; Kakehi A; Okura M; Minabe H; Yokoyama Y; Otsuka F; Higashikage A
    J Infect Chemother; 2022 Jul; 28(7):918-922. PubMed ID: 35351391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2017-2021.
    ; ; ; ;
    Can Commun Dis Rep; 2023 May; 49(5):235-252. PubMed ID: 38425696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory-based surveillance of antimicrobial resistance in regions of Kenya: An assessment of capacities, practices, and barriers by means of multi-facility survey.
    Moirongo RM; Aglanu LM; Lamshöft M; Adero BO; Yator S; Anyona S; May J; Lorenz E; Eibach D
    Front Public Health; 2022; 10():1003178. PubMed ID: 36518572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
    Tsuzuki S; Matsunaga N; Yahara K; Gu Y; Hayakawa K; Hirabayashi A; Kajihara T; Sugai M; Shibayama K; Ohmagari N
    J Infect Chemother; 2020 Apr; 26(4):367-371. PubMed ID: 31801696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.